Jim Cramer: This Industrial Stock Is Doing 'Very Well'; Here's His Take On Palantir

On CNBC's “Mad Money Lightning Round,” Jim Cramer said he likes Enbridge Inc. ENB. “I trust that management team,” he added.

On May 10, Enbridge posted better-than-expected quarterly earnings.

Lazard, Inc. LAZ is a good buy here, Cramer said. “I do believe that things are going to get a little less onerous… when it comes to takeovers.”

On May 20, Lazard announced that Ben Braun joined the firm as managing director and global head of Media, Entertainment & Sports Advisory.

Cramer recommended staying away from AST SpaceMobile, Inc. ASTS as there are so many great companies. “We don't need to be in that one,” he added.

On May 15, AST SpaceMobile and AT&T announced a definitive commercial agreement.

The “Mad Money” host said Advanced Drainage Systems, Inc. WMS is “another incredible infrastructure play.”

On May 16, Advanced Drainage Systems posted upbeat quarterly sales.

Zebra Technologies Corporation ZBRA has “made it all the way back. Halleluiah for them,” Cramer said.

On May 20, Zebra Technologies announced the launch of a $500 million senior unsecured note private offering.

Jacobs Solutions Inc. J is doing “very well,” Cramer said. “I would want to own it.”

Last week, Jacobs announced the appointment of Venk Nathamuni as the company’s new chief financial officer, effective June 3.

“Let's stick with domestic,” Cramer said when asked about Petróleo Brasileiro S.A. – Petrobras PBR.

Last week, Brazil President Luiz Inacio Lula da Silva fired Petrobras CEO following a dispute over dividend payments.

Cramer said he is not going to say no to Sarepta Therapeutics, Inc. SRPT. “It has been a company that has not made money but is about to break out and make money,” he noted.

On May 1, Sarepta Therapeutics reported better-than-expected first-quarter financial results.

Palantir Technologies Inc. PLTR is fine, Cramer said. “It's got good commercial and good military.”

On May 6, Palantir said first-quarter revenue increased 21% year-over-year to $634 million, which beat the consensus estimate of $625.431 million.

Price Action:

• Lazard shares gained 0.4% to settle at $41.16 on Tuesday.
• Enbridge shares closed at $36.78 on Tuesday.
• Petroleo Brasileiro shares slipped 0.7% to settle at $15.02.
• Advanced Drainage System shares gained 1.1% to settle at $179.24 on Tuesday.
• AST SpaceMobile shares fell 10.8% to settle at $4.71.
• Zebra Technologies shares gained 0.5% to close at $321.78 on Tuesday.
• Palantir shares fell 1.8% to close at $21.24.
• Sarepta Therapeutics shares fell 1.3% to settle at $129.12.
• Shares of Jacobs Solutions gained 1.4% to close at $ 138.79 during Tuesday's session.

Read Next: Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month

Photo: Shutterstock